Analytical evaluation of QuantiFERON- Plus and QuantiFERON- Gold In-tube assays in subjects with or without tuberculosis [PDF]
Tuberculosis, 2017 The QuantiFERON-TB Gold Plus (QFT-Plus) represents the new QuantiFERON-TB Gold In-tube (QFT-GIT) to identify latent tuberculosis infection (LTBI). The main differences is the addition of a new tube containing shorter peptides stimulating CD8 T-cells. Aim
Daniela Maria Cirillo +2 more
exaly +3 more sources
Low concordance between QIAreach QuantiFERON-TB, a novel interferon-gamma release assay, and QuantiFERON-TB Gold Plus, in a population-based survey in Blantyre, Malawi [PDF]
Journal of Clinical MicrobiologyUrgent improvements in the diagnosis and management of Mycobacterium tuberculosis infection are required to reach End TB goals. Conventional interferon-gamma release assays (IGRAs), such as QuantiFERON-TB Gold Plus (QFT-Plus), require substantial ...
Hannah M. Rickman +8 more
doaj +2 more sources
PLoS ONE, 2020 BackgroundWe investigated changes in the interferon-γ levels before and after treatment of latent tuberculosis infection (LTBI) using QuantiFERON-TB Gold Plus (QFT-Plus) and QuantiFERON-TB Gold In-Tube (QFT-GIT) assays.
Ock-Hwa Kim +6 more
doaj +4 more sources
Prevalence of latent tuberculosis infection among foreign students in Lübeck, Germany tested with QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus [PDF]
Journal of Occupational Medicine and Toxicology, 2017 Background The tuberculosis (TB) incidence rate in foreign-born individuals has been increasing in Germany in recent years. Foreign students may be an important source of latent tuberculosis infection (LTBI) in low-incidence countries.
Elia Noemi Gallegos Morales +4 more
doaj +3 more sources
QuantiFERON-TB Gold Plus Performance in Children: A Narrative Review. [PDF]
Pediatr Infect Dis J, 2023 This review summarizes studies evaluating the performance of the QuantiFERON-TB Gold Plus (QFT-Plus) interferon-gamma release assay (IGRA) test for Mycobacterium tuberculosis (Mtb) infection in children. Literature searching was conducted using PubMed, MEDLINE and Embase (January 2017 to December 2021) and the terms “children” or “pediatric” and “IGRAs”
Buonsenso D +3 more
europepmc +4 more sources
Comparative Evaluation of Diagnostic Performance: Standard E TB Feron ELISA vs QuantiFERON-TB Gold Plus for Latent Tuberculosis Infection Detection in Diverse Risk Groups in Bangladesh [PDF]
Infection and Drug ResistanceMohammad Khaja Mafij Uddin,1 Ashabul Islam,1 Maha Sultana Jabin,1 Tahmina Alam,2 Salwa Khair,1 Jannatul Ferdous,1 Rumana Nasrin,1 S M Mazidur Rahman,1 Stephane Pouzol,3 Jonathan Hoffmann,3 Sayera Banu1 1Infectious Diseases Division, Icddr,B, Dhaka ...
Uddin MKM +10 more
doaj +2 more sources
Comparing the Diagnostic Performance of QuantiFERON-TB Gold Plus to Other Tests of Latent Tuberculosis Infection: A Systematic Review and Meta-analysis [PDF]
Clinical Infectious Diseases, 2021 Chi Eun Oh +2 more
exaly +2 more sources
BMJ Open Ophthalmology, 2021 Tuberculosis (TB)-associated uveitis is a common cause of infectious uveitis in the developing world. Diagnosis of TB uveitis remains a challenge. The role of interferon gamma release assays (IGRAs) is uncertain.
M A Rehman Siddiqui +2 more
doaj +1 more source
Pulmonology, 2022 Objective 1) to compare the QIAreachTM QuantiFERON-TB (QIAreach QFT) vs. QuantiFERON®-TB Gold Plus assay (QFT-Plus) to detect tuberculosis (TB) infection; 2) to evaluate diagnostic sensitivity of QIAreach QFT using active TB as surrogate for TB infection;
K. Fukushima +5 more
doaj +3 more sources
Frontiers in Microbiology, 2021 As an ancient infectious disease, tuberculosis (TB) is still the leading cause of death from a single infectious agent worldwide. Latent TB infection (LTBI) has been recognized as the largest source of new TB cases and is one of the biggest obstacles to ...
Wenping Gong, Xueqiong Wu
doaj +1 more source